Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 3
2008 1
2009 2
2010 2
2011 3
2012 2
2013 4
2014 4
2015 2
2016 6
2017 6
2018 12
2019 13
2020 16
2021 14
2022 18
2023 13
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
A comparison of the sociodemographic, medical, and psychosocial characteristics of adolescents and young adults diagnosed with cancer recruited in-person and online: A Canadian cross-sectional survey.
Bender JL, Akinnibosun R, Puri N, D'Agostino N, Drake EK, Tsimicalis A, Howard AF, Garland SN, Chalifour K, Gupta AA. Bender JL, et al. Among authors: gupta aa. Digit Health. 2023 Oct 25;9:20552076231205278. doi: 10.1177/20552076231205278. eCollection 2023 Jan-Dec. Digit Health. 2023. PMID: 37900258 Free PMC article.
Clinico-demographic characteristics and outcomes of radiation-induced sarcomas (RIS): a CanSaRCC study.
Ribeiro MF, Peretz Soroka H, Bhura Z, Hirsch I, Wunder J, Ferguson P, Tsoi K, Brar S, Gladdy R, Swallow C, Chung P, Catton C, Wong P, Watson G, Razak ARA, Gupta AA, Shultz D. Ribeiro MF, et al. Among authors: gupta aa. Ther Adv Med Oncol. 2023 Sep 28;15:17588359231198943. doi: 10.1177/17588359231198943. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 37781501 Free PMC article.
Real-world experience of tyrosine kinase inhibitors in children, adolescents and adults with relapsed or refractory bone tumours: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) study.
Peretz Soroka H, Vora T, Noujaim J, Marcoux N, Cohen-Gogo S, Alcindor T, Holloway C, Rodrigues C, Karachiwala H, Alvi S, Lee U, Cheng S, Banerji S, Oberoi S, Feng X, Smrke A, Simmons C, Razak AA, Gupta AA. Peretz Soroka H, et al. Among authors: gupta aa. Cancer Med. 2023 Sep;12(18):18872-18881. doi: 10.1002/cam4.6515. Epub 2023 Sep 19. Cancer Med. 2023. PMID: 37724607 Free PMC article.
Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.
Salawu A, Wang BX, Han M, Geady C, Heirali A, Berman HK, Pfister TD, Hernando-Calvo A, Al-Ezzi EM, Stayner LA, Gupta AA, Ayodele O, Lam B, Hansen AR, Spreafico A, Bedard PL, Butler MO, Avery L, Coburn B, Haibe-Kains B, Siu LL, Abdul Razak AR. Salawu A, et al. Among authors: gupta aa. Clin Cancer Res. 2023 Oct 13;29(20):4128-4138. doi: 10.1158/1078-0432.CCR-23-1137. Clin Cancer Res. 2023. PMID: 37566240
103 results